What kind of patients with castration-naïve prostate cancer can benefit from upfront docetaxel and abiraterone: A systematic review and a network meta-analysis

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (NSFC 81672547, 81402110)
  • Science and Technology Support Program of Sichuan Province (2015SZ0230-3)

This publication has 26 references indexed in Scilit: